| Literature DB >> 29246973 |
Jonàs Juan-Mateu1, Maria Inês Alvelos2, Jean-Valéry Turatsinze2, Olatz Villate2, Esther Lizarraga-Mollinedo2, Fabio Arturo Grieco2, Laura Marroquí2, Marco Bugliani3, Piero Marchetti3, Décio L Eizirik1,4.
Abstract
Progressive failure of insulin-producing β-cells is the central event leading to diabetes, but the signaling networks controlling β-cell fate remain poorly understood. Here we show that SRp55, a splicing factor regulated by the diabetes susceptibility gene GLIS3, has a major role in maintaining the function and survival of human β-cells. RNA sequencing analysis revealed that SRp55 regulates the splicing of genes involved in cell survival and death, insulin secretion, and c-Jun N-terminal kinase (JNK) signaling. In particular, SRp55-mediated splicing changes modulate the function of the proapoptotic proteins BIM and BAX, JNK signaling, and endoplasmic reticulum stress, explaining why SRp55 depletion triggers β-cell apoptosis. Furthermore, SRp55 depletion inhibits β-cell mitochondrial function, explaining the observed decrease in insulin release. These data unveil a novel layer of regulation of human β-cell function and survival, namely alternative splicing modulated by key splicing regulators such as SRp55, that may cross talk with candidate genes for diabetes.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29246973 PMCID: PMC5828453 DOI: 10.2337/db17-0736
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461